SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...
Over the past two decades, management of pain in patients with systemic lupus erythematosus (SLE) has come to rely less on higher-risk therapies like opioids, although prescribing intensity remains ...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that ...
SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...
It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol Hill purple at the 2026 National Lupus Advocacy Summit this April!
When people with systemic lupus erythematosus (SLE) actively participate in shared decision-making (SDM) about their disease with their doctors’, trust is likely to increase. A new study found that ...
Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...
Please provide your email address to receive an email when new articles are posted on . The acceptable threshold for glucocorticoid use for lupus maintenance therapy should be 5 mg per day prednisone ...
The SLECRISK tool for predicting cardiovascular disease among patients with systemic lupus erythematosus produces more accurate predictions compared with the American College of Cardiology/American ...
AJMC ®: What strategies have you found effective for increasing the screening and early diagnosis of lupus nephritis in patients with either diagnosed or suspected systemic lupus erythematosus (SLE)?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results